Though PD1/PD-L1 blockade seems to have unimpressive efficacy in r/r DLBCL, another immune checkpoint CD47, considered as macrophage checkpoint, has emerged to be a promising target (Fig. 1). Here, PDCD1 is linked to diffuse large B-cell lymphoma.